Statins do not have an antagonistic effect on the antiplatelet effect of clopidogrel but aspirin is still the antiplatelet agent of choice for ACS patients Current guidelines advise the aggressive ...
Credit: Getty Images. “Migratory polyarthritis secondary to clopidogrel is a diagnosis of exclusion,” the study authors concluded, adding, “Early diagnosis and timely intervention are essential, as ...
Current evidence seems to indicate that due to individual variability in response to clopidogrel, as many as 30% of patients on maintenance clopidogrel (75 mg/day) may show elevated platelet ...
You have full access to this article via your institution. The Clopidogrel as Adjunctive Reperfusion Therapy–Thrombolysis In Myocardial Infarction study (CLARITY-TIMI) 28 trial was an international, ...
The effect of single as compared with dual antiplatelet treatment on bleeding and thromboembolic events after transcatheter aortic-valve implantation (TAVI) in patients who do not have an indication ...
ATLANTA, GA (May 20, 2022) – Results from a real-world study investigating safety and effectiveness of clopidogrel versus aspirin monotherapy beyond 12 months after PCI in high-risk patients during ...
PARIS, France—Older patients with non-ST-elevation acute coronary syndrome treated with ticagrelor (Brilinta; AstraZeneca) are at a significantly increased risk of bleeding when compared with patients ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback